News
BDSX
22.76
-2.11%
-0.49
Weekly Report: what happened at BDSX last week (0810-0814)?
Weekly Report · 1d ago
Biodesix Earnings Call Highlights Rapid Growth Path
TipRanks · 1d ago
Veteran Insider Makes Bold New Bet on Biotech Player
TipRanks · 4d ago
Biodesix Insider Makes Bold New Move With Fresh Stock Purchase
TipRanks · 5d ago
Biodesix, Inc. (BDSX) Hit a 52 Week High, Can the Run Continue?
NASDAQ · 08/11 13:15
Biotech Stocks At 52-Week Highs - SLN +29% & ABCL +34% On Positive Trial Data, CPIX, CLDX, BDSX
NASDAQ · 08/11 08:05
Biodesix Is Maintained at Buy by Canaccord Genuity
Dow Jones · 08/10 12:26
Biodesix price target raised to $35 from $27 at Canaccord
TipRanks · 08/10 11:07
Weekly Report: what happened at BDSX last week (0803-0807)?
Weekly Report · 08/10 10:11
Biodesix Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 08/06 18:44
Biodesix Price Target Raised to $27.00/Share From $26.00 by HC Wainwright & Co.
Dow Jones · 08/06 18:44
HC Wainwright & Co. Maintains Buy on Biodesix, Raises Price Target to $27
Benzinga · 08/06 18:34
Biodesix price target raised to $27 from $26 at H.C. Wainwright
TipRanks · 08/06 16:35
Analysts Have Conflicting Sentiments on These Healthcare Companies: Biodesix (BDSX), Incyte (INCY) and Zimmer Biomet Holdings (ZBH)
TipRanks · 08/06 13:50
Analysts Conflicted on These Healthcare Names: Aurora Cannabis (ACB), Biodesix (BDSX) and Insulet (PODD)
TipRanks · 08/06 12:40
Analysts Offer Insights on Healthcare Companies: Biodesix (BDSX), Pacific Biosciences (PACB) and Odyssey Therapeutics, Inc. (ODTX)
TipRanks · 08/06 09:50
Press Release: Biodesix Announces Second Quarter 2026 Results and Highlights
Dow Jones · 08/05 20:01
Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference
Barchart · 08/04 05:00
Weekly Report: what happened at BDSX last week (0727-0731)?
Weekly Report · 08/03 10:10
Analysts Conflicted on These Healthcare Names: Myriad Genetics (MYGN) and Biodesix (BDSX)
TipRanks · 08/01 09:01
More
Webull provides a variety of real-time BDSX stock news. You can receive the latest news about BIODESIX INC through multiple platforms. This information may help you make smarter investment decisions.
About BDSX
Biodesix, Inc. is a diagnostic solutions company. The Company's business includes Biodesix Lung Diagnostic Testing and Biodesix Development Services. Its Biodesix Lung Diagnostic Testing provides lung diagnostic testing services for healthcare providers through five blood-based tests. Its Biodesix Development Services supports global biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that enable the development of diagnostic tests, tools, and therapeutics. The Company offers Nodify Lung tests and IQLung tests that assess cancer risk and provide treatment guidance following a lung cancer diagnosis. The Nodify Lung tests include Nodify CDT and Nodify XL2 tests, which evaluate the risk of lung cancer in lung nodules. The GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests are used in the diagnosis of lung cancer to detect tumor mutations and assess the patient’s immune system status.